Geneva, June 4 -- International Clinical Trials Registry received information related to the study (EUCTR2025-000121-13-Outside-EU/EEA) titled 'A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D' on May 21.
Study Type: Interventional clinical trial of medicinal product
Study Design:
Controlled: no Randomised: no Open: yes Single blind: no Double blind: no Parallel group: no Cross over: no Other: no If controlled, specify comparator, Other Medicinial Product: no Placebo: no Other: no
Primary Sponsor: Zealand Pharma A/S
Condition:
Severe hypoglycemia in Type 1 Diabetes (T1D) patients
Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
Intervention: ...